Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
Common Stock · CUSIP: 76243J105
Event date: 2025-12-31
- Filing-level shares
- 6,210,916
- Percent of class
- 9.30%
- The Vanguard Group
Shares: 6,210,916 · Class: 9.30%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000254
- Form type
- SCHEDULE 13G/A
- Filer
- RHYTHM PHARMACEUTICALS, INC.
- CIK
- CIK 1649904
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership